Author Question: A patient, age 26, is admitted to the burn unit with partial- and full-thickness burns to 20 of his ... (Read 65 times)

javeds

  • Hero Member
  • *****
  • Posts: 570
A patient, age 26, is admitted to the burn unit with partial- and full-thickness burns to 20 of his body surface area as well as smoke-inhalation injury.
 
  Carbon monoxide intoxication secondary to smoke inhalation is often fatal because carbon monoxide a. binds with hemoglobin in place of oxygen.
  b. interferes with oxygen intake.
  c. is a respiratory depressant.
  d. is a toxic agent.

Question 2

During an assessment the nurse notes that an older patient has a gray discoloration of the skin. Which health problem does the nurse suspect the patient is experiencing?
 
  A) Emphysema
  B) Lung abscess
  C) Chronic bronchitis
  D) Peripheral vascular disease



flannelavenger

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A
Carbon monoxide poisoning is likely if the patient has been in an enclosed area. Carbon monoxide displaces oxygen by binding with the hemoglobin.

Answer to Question 2

C
Feedback:
In the presence of chronic bronchitis, the patient can have a blue or gray discoloration of the skin caused by a lack of oxygen binding to the hemoglobin. Ruddy, pink complexions often occur with emphysema and are associated with hypoxia from a high carbon dioxide level in the blood. Specific skin color changes are not associated with lung abscess or peripheral vascular disease.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Always store hazardous household chemicals in their original containers out of reach of children. These include bleach, paint, strippers and products containing turpentine, garden chemicals, oven cleaners, fondue fuels, nail polish, and nail polish remover.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library